Login
$GUTS
$0.88 -$0.19 (17.76%) Close

$GUTS 8-K SEC Filings

Filed On Filing
22 Oct 2026 8-K: Cost Associated with Exit or Disposal Activities; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers +1 more

Fractyl Health Sharpens Focus on Revita Following Positive Pivotal Results, Advancing Toward Planned FDA De Novo Submission in Post-GLP-1 Weight Maintenance

16 Oct 2026 8-K: Regulation FD Disclosure; Other Events

October 2026 REMAIN-1 Pivotal Study Positive Topline 6 Month Results for Revita in Post-GLP-1 Weight Maintenance Revita is for investigational use only in the United States. Revita has a CE mark in the EU/UK. REMAIN-1 is an ongoing study...

01 Oct 2026 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Fractyl Health, Inc., a corporation organized and existing under the General Corporation Law of the State of Delaware (the “DGCL”), certifies:

24 Sep 2026 8-K: Submission of Matters to a Vote of Security Holders

On September 24, 2026, Fractyl Health, Inc. (the “Company”) held its Special Meeting of Stockholders (the “Special Meeting”). Of the 159,179,848, shares of the Company’s common stock outstanding as of the record date of August 21, 2026, ...

11 Sep 2026 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule

As previously disclosed, on March 13, 2026, Fractyl Health, Inc. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the listing of its common ...

10 Aug 2026 8-K: Results of Operations and Financial Condition
15 Jul 2026 8-K: Regulation FD Disclosure; Other Events
11 Jun 2026 8-K: Submission of Matters to a Vote of Security Holders
04 Jun 2026 8-K: Regulation FD Disclosure; Other Events
12 May 2026 8-K: Results of Operations and Financial Condition
11 May 2026 8-K: Regulation FD Disclosure
24 Mar 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
17 Mar 2026 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
26 Feb 2026 8-K: Regulation FD Disclosure
29 Jan 2026 8-K: Regulation FD Disclosure; Other Events
06 Jan 2026 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
05 Jan 2026 8-K: Results of Operations and Financial Condition; Other Events
16 Dec 2025 8-K: Regulation FD Disclosure; Other Events
02 Dec 2025 8-K: Regulation FD Disclosure; Other Events
12 Nov 2025 8-K: Results of Operations and Financial Condition

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support